SCHEMBL252983

SCHEMBL252983

CCOC(=O)c1c(C)nc2ncccc2c1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.47
LMNA P02545 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 6/20 0.47
ALDH1A1 P00352 4/20 0.47
HPGD P15428 2/20 0.47
RAB9A P51151 2/20 0.47
MAPT P10636 2/20 0.47
NPC1 O15118 1/20 0.47
GAA P10253 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
L3MBTL1 Q9Y468 3/20 0.45
CYP1A2 P05177 1/20 0.44
ADORA3 P0DMS8 2/20 0.44
HSD17B10 Q99714 2/20 0.43
MAOB P27338 1/20 0.42
TP53 P04637 1/20 0.42
GABRP O00591 1/20 0.42
GABRD O14764 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1060409 0.90 L3MBTL1 (0.45) SMN1; SMN2LMNAMEN1KMT2AKDM4E
SCHEMBL1468948 0.80 SMN1; SMN2 (0.67) SMN1; SMN2LMNAMEN1KMT2AKDM4E
SCHEMBL9389155 0.78 PDE4B (0.47) SMN1; SMN2LMNAMEN1KMT2AKDM4E
SCHEMBL253808 0.77 ALDH1A1 (0.54) SMN1; SMN2LMNAMEN1KMT2AKDM4E
SCHEMBL26678225 0.77 BRD4 (0.48) SMN1; SMN2MEN1KMT2AKDM4EALDH1A1
SCHEMBL3393412 0.77 ALDH1A1 (0.50) SMN1; SMN2LMNAMEN1KMT2AKDM4E
SCHEMBL3482516 0.77 MAOB (0.43) SMN1; SMN2MEN1KMT2AKDM4EALDH1A1
SCHEMBL30572385 0.77 KDM4E (0.49) SMN1; SMN2LMNAMEN1KMT2AKDM4E
SCHEMBL30572436 0.77 KDM4E (0.49) SMN1; SMN2LMNAMEN1KMT2AKDM4E
SCHEMBL10995653 0.77 HPGD (0.46) SMN1; SMN2LMNAMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401275-B1 NAPHTHYRIDINE DERIVATIVES HAVING BRONCHODILATING ACTIVITY RESPIRATORIUS AB (SE) 2013-07-24 EP disclosed
EP-2401275-B1 NAPHTHYRIDINE DERIVATIVES HAVING BRONCHODILATING ACTIVITY RESPIRATORIUS AB (SE) 2013-07-24 EP disclosed
US-8415333-B2 Bronchodilating diazaheteroaryls RESPIRATORIOUS AB (SE) 2013-04-09 US disclosed
US-8415333-B2 Bronchodilating diazaheteroaryls RESPIRATORIOUS AB (SE) 2013-04-09 US disclosed
US-8415333-B2 Bronchodilating diazaheteroaryls RESPIRATORIOUS AB (SE) 2013-04-09 US disclosed
US-20120040942-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS RESPIRATORIUS AB (SE) 2012-02-16 US disclosed
EP-2401275-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS Respiratorius AB (SE) 2012-01-04 EP disclosed
WO-2010097410-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS RESPIRATORIUS AB (SE) 2010-09-02 WO disclosed
WO-2010097410-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS RESPIRATORIUS AB (SE) 2010-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040942-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS CHRM3, ADRB1, ADRB3 SMN1; SMN2 4137/4885LMNA 4429/4885MEN1 3494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.